CDW Bounces, but Options and Shorts Suggest Caution Ahead of November Print

Short interest adds nuance rather than confirming the bear case. At roughly 6.7% of the free float, the short position is meaningful but has been declining. It fell about 4% over the past month, with the most recent week showing a further 3.9% reduction to around 8.7 million shares. The lending market is loose: availability is running near 792%, well above even its 52-week low of 484%, and the cost to borrow is just 0.42%, barely changed over the past year. There is no squeeze dynamic, no supply crunch, and no signal of aggressive new short-selling. Bears are trimming rather than pressing.

The Street is modestly constructive but lacks conviction. Morgan Stanley carries an Overweight with a $171 target, and JP Morgan upgraded to Overweight in May. Barclays, however, sits at Equal-Weight and trimmed its target slightly to $148 in September, while Citi holds Neutral with a $145 target. The mean target across the group is around $159, implying roughly 16% upside from current levels. On valuation, the stock trades at a P/E of 11.6x and EV/EBITDA near 9.8x, both reasonable for a technology distributor, and the forward earnings revision factor ranks in the 92nd percentile of the ORTEX universe, indicating the earnings estimate trend is strongly positive despite the recent share price weakness. Against that, EPS surprise ranks only in the 31st percentile, and EPS momentum over both 30 and 90 days is below the sector midpoint, a tension between where estimates are heading and how CDW has been delivering against them.

Institutional ownership is broad and mostly passive. BlackRock recently added to its position and holds 12.2% of shares. The most notable structural move in the 13D/G register is The Vanguard Group's exit from its direct holding, filing a 13G/A showing its direct stake reduced to zero from 12.78%. That stake has effectively migrated into separately disclosed Vanguard Capital Management and Vanguard Portfolio Management vehicles, which together hold around 14% of the company. This is a restructuring of how Vanguard reports rather than a disposal, but it is worth tracking. No 13D activist is on the register. Insider activity over the past 90 days has been a net negative of around 26,700 shares and roughly $3.7 million in value, though the specific transactions are mostly compensation-related awards and a small tax-withholding sale, not discretionary market sales by senior executives.

Wikipedia attention toward CDW has ticked up to a z-score of 2.1 against its own 90-day history, a measure of retail interest rather than a financial signal. None of the alternative data sets covering CDW have been measured to lead reported revenue or earnings figures, so the attention reading is colour rather than an indicator.

With the November 4 earnings date 27 days away, the key question is whether the recovery week marks genuine re-rating or simply a bounce within a down-trend that has taken the stock roughly 10% lower over the past month. The put/call ratio's persistence near the top of its 12-month range, against a backdrop of shorts that are retreating rather than pressing, is the tension worth watching into that print.